Cargando…
Synthetic glycolipid-based TLR4 antagonists negatively regulate TRIF-dependent TLR4 signalling in human macrophages
TLRs, including TLR4, play a crucial role in inflammatory-based diseases, and TLR4 has been identified as a therapeutic target for pharmacological intervention. In previous studies, we investigated the potential of FP7, a novel synthetic glycolipid active as a TLR4 antagonist, to inhibit haematopoie...
Autores principales: | Palmer, Charys, Facchini, Fabio A, Jones, Richard PO, Neumann, Frank, Peri, Francesco, Pirianov, Grisha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054148/ https://www.ncbi.nlm.nih.gov/pubmed/33858242 http://dx.doi.org/10.1177/17534259211005840 |
Ejemplares similares
-
The synthetic glycolipid-based TLR4 antagonist FP7 negatively
regulates in vitro and in vivo haematopoietic
and non-haematopoietic vascular TLR4 signalling
por: Palmer, Charys, et al.
Publicado: (2018) -
Mycobacterial Phenolic Glycolipids Selectively Disable TRIF-Dependent TLR4 Signaling in Macrophages
por: Oldenburg, Reid, et al.
Publicado: (2018) -
Synthetic Glycolipids
as Molecular Vaccine Adjuvants:
Mechanism of Action in Human Cells and In Vivo Activity
por: Facchini, Fabio A., et al.
Publicado: (2021) -
Bacterial vesicles block viral replication in macrophages via TLR4-TRIF-axis
por: Bierwagen, Jeff, et al.
Publicado: (2023) -
Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties
por: Cochet, Florent, et al.
Publicado: (2019)